Transformation Talks: Navigating the Vaccines’ Renaissance

The pandemic has revived interest in vaccines, but will this renaissance last forever? 
Multimedia
Category:
Published on:
December 16, 2021

Tune into this episode of “Transformation Talks” to learn more about the past, present, and future of the vaccine industry, from the lack of innovation for the last 20 years to new technologies like mRNA platforms and whole-cell vaccines. Our host Kenny Carberry, Associate Director of Clinical Development at Alira Health, and our expert in vaccines Bernd Schollmeier, VP of Global Market Access – Vaccines, will discuss the ups and downs of the vaccine industry, how the COVID pandemic has transformed it, and what is coming up next.

Follow us on LinkedIn to be the first one to sign up for our exclusive series of appointments with vaccine experts!

LISTEN TO THE EPISODE BELOW

Related news

News September 8, 2023
Alira Health Partners With Col·legi de Metges de Barcelona
We are pleased to partner with Col·legi de Metges de Barcelona (CoMB), an institution that represents and serves the almost 39,000 physicians in Barcelona.
Market Access Spain Startups
Events August 10, 2023
12th EPP Life Sciences Pricing Forum
We are excited to speak at the 12th EPP Life Sciences Pricing Forum for pricing directors and executives in Life Sciences.
EU Market Access
Events July 31, 2023
ESMO Congress
We are excited to join the ESMO Congress in Madrid. to disseminate the latest cutting-edge data for oncologists and other stakeholders.
Drug Development Market Access Oncology Spain
Publications July 25, 2023
Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets
Our Market Access experts have identified risks and opportunities associated with improving access to medicines in emerging countries.
Market Access Pharma
Blog June 30, 2023
Why You Need Market Access and How to Get Started
Start reading to learn about the importance of market access in pharma and MedTech and the key steps to get started.
Market Access MedTech Pharma
Blog April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Blog April 17, 2023
Pharmaceutical Market Access in the UK: A Changing Landscape
Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.
Market Access Pharma UK
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.